Cymbalta helps fibromyalgia pain, Lilly says

August 21, 2007
Eli Lilly and Co.'s depression drug Cymbalta dampened pain in patients with fibromyalgia and has asked the Food and Drug Administration to approve it for secondary use, the Indianapolis pharmaceutical maker said today. Patients experienced less pain beginning a week after taking the treatment, a study showed.

Two percent to 4 percent of Americans, mostly women, suffer from the chronic condition, which causes fatigue as well as pain in muscles, ligaments and tendons.

Cymbalta generated $519.5 million of Lilly's $4.6 billion in second-quarter sales.
Source: XMLFULL/XMLFull3734.xml

Recent Articles by IBJ Staff

Comments powered by Disqus